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Introduction
Alzheimer's disease (AD) affects 35-40 million patients worldwide and currently is incurable. [1] The quest to develop diagnostic tools for AD is currently an intense area of research in neuroscience in order to diagnose AD patients before they become symptomatic owing to already well-established structural and functional changes in the brain. Currently, the diagnosis of this disease can be achieved through the use of positron emission tomography (PET) using molecules radiolabelled with carbon-11 or fluorine-18, although some of the lead candidates display undesired off-target binding in the brain, which could compromise their utility in molecular imaging. [2] A promising target for the diagnosis of AD involves the muscarinic acetylcholine subtype M 2 receptor, as a selective loss in the cerebral cortex of M 2 receptors over the M 1 subtype receptors has been linked to AD. [3] Therefore, earlier detection of AD through a selective M 2 receptor imaging agent would provide a more favourable prognosis and earlier intervention at presymptomatic stages that could slow disease progression. Derivatives of thiadiazolyltetrahydropyridine (TZTP) were evaluated in the past for their muscarinic receptor selectivity. [4] Further investigation by preparing fluorinated analogues led to the most promising M 2 selective compound being the fluoropropylthio-TZTP (FP-TZTP) derivative. [5] Radiolabelling the analogue with fluorine-18 to form [ 18 F]FP-TZTP allowed in vivo imaging in animals that demonstrated favourable blood-brain barrier transport and rapid tissue uptake, and confirmed M 2 receptor selectivity. [5] [6] [7] Owing to these promising results, [ [5] This convoluted radiosynthesis produced [ 18 F]FP-TZTP in 34 AE 4 % radiochemical yield (RCY) in 85 min with a molar activity of 85 GBq mmol À1 decay-corrected to end-of-bombardment (EOB). The radiolabelling procedure was improved through the use of an automated radiosynthesis module and a new one-step radiolabelling precursor featuring a mesylate salt. [8] Although the entire synthesis time was shorter (60 min), the RCY was lower (19 AE 2 % decay-corrected to endof-synthesis (EOS)); however, this may be attributed to the mesylate precursor containing a 10 % impurity of 2-propanol. Similarly, an [ 18 F]FP-TZTP one-step precursor incorporating a tosylate leaving group was proposed. [9] Using the automated TRACERlab FX FN F-radiotracers, namely shorter reaction times, reduced amounts of chemical reagents, and higher radiochemical yields, [10, 11] are contributing to the rising interest in the use of this technology. [12] [13] [14] Using the commercially available Advion NanoTek microfluidic synthesis system, we attached a custom-made electrical board to modify the system to incorporate HPLC and solid phase extraction (SPE) purification and subsequent formulation. [15] This customised system has produced a range of 18 [15] and [
18 F]MEL050. [16] More recently, it was demonstrated that this system was capable of producing up to three different 18 F-radiotracers sequentially, using the same starting batch of [ 18 F]fluoride. [17] Herein, we discuss the first account of the microfluidic radiolabelling optimisation and production of the muscarinic M 2 imaging agent [ 
Results and Discussion

F-Fluorination Optimisation
Previously, the mesylate salt of FP-TZTP was initially disregarded as the preferred radiolabelling precursor owing to the presence of a 10 % impurity of 2-propanol. [8] Nonetheless, as a commercial source of the precursor in excellent purity is now available, in our study, we radiofluorinated the mesyl FP-TZTP precursor using the Advion NanoTek system to produce [ (Fig. 1) , flow rate (hence, residence time; Fig. 2 ), and stoichiometric ratio (amount of precursor mass; Fig. 3 ), which were altered in the Discovery Mode of the NanoTek software. [18] Initial radiolabelling optimisation using acetonitrile as a solvent led to the maximum 18 F-incorporation yield of 39 % (unisolated, determined by radio-HPLC as percentage of product peak area over entire radiochromatogram area) at 1908C. [19] [20] [21] [22] In the case of [
18 F]FP-TZTP, it appeared that anhydrous radiolabelling conditions were vital to achieve high levels of 18 F-incorporation. By altering the reaction solvent to DMF, the optimal 18 F-incorporation yield of 78 % at 1908C was achieved (Fig. 1 ). There was no significant difference in 18 F-incorporation yield when K 2.2.2 /K 2 CO 3 or tetraeathylammonium bicarbonate were used as the activating agents.
The optimal flow rate for the reaction was 10 mL min À1 of the precursor solution and of the K[ 18 F]F.K 222 complex (total flow rate of 20 mL min À1 ; residence time 47 s), and there was no significant difference in 18 F-incorporation yield when a total flow rate of 40 mL min À1 was employed (residence time 23.6 s, Fig. 2 ). Interestingly, higher amounts of precursor mass, obtained by modifying the flow ratio of the reagents, resulted in decreased yields of [ 18 F]FP-TZTP (Fig. 3 ). The modification of flow ratios to achieve higher precursor mass was performed using the same bolus volume of K[ 
F-incorporation. (The difference in
18 F-incorporation yield from previous experiments was due to the different analytical method selected to expedite the collection of results. Additionally, whereas radio-HPLC yield tends to overestimate the amount of organic radio-products, radio-TLC yield provides complete recovery of unreacted [ 18 F]fluoride, but owing to their volatility, some organic radio-products may be lost. The use of newer monolithic or polymeric HPLC stationary phases reduces this discrepancy. [23] ) The precursor concentration used in the present study (2 mg mL À1 ) was significantly decreased from 6 mg mL À1 used in a vessel radiosynthesis module. [8, 9] Although these studies both used 3 mg of the precursor molecule in 500 mL of solvent, the entire solution including the K[ F]FP-TZTP was extrapolated based on the radioactivity recovered from the 'dummy' reactions, i.e. RCY ¼ product activity/estimated starting activity based on 'dummy' reaction, corrected to EOS. [17] Although three 'dummy' reactions may not always be necessary, it is recommended that at least two are performed to ensure reproducibility. Performing 'dummy' reactions also increases the overall total amount of precursor used in the radiosynthesis (in our case, an additional 40 mg of precursor is used per 'dummy' reaction) and the time required to perform these reactions is additional to the synthesis time required to produce the Once the 18 F-fluorination reaction was complete, it was washed out of the microreactor with additional DMF and loaded onto an HPLC injector loop containing a radiodetector. The sample was then loaded onto a semipreparative HPLC column (Fig. 4a) and the product peak collected (at 12-15 min) into a two-necked round-bottom vial with the aid of another radiodetector. Additional water (15 mL) was added to the collected fraction before it was loaded onto a Sep-pak C18 Light SPE cartridge and eluted with 1.5 mL EtOH into the vial of an additional NanoTek Concentrator module. The EtOH was evaporated at 908C for 15 min, before the residue was reconstituted in 1 mL of 10 % ethanolic saline solution as described previously. [16, 17] Under these conditions, [
18 F]FP-TZTP was obtained in 26 AE 10 % RCY (n ¼ 15), with a molar activity of 182 AE 65 GBq mmol À1 at EOS. The entire radiosynthesis was completed in 49 AE 2 min and radiochemical purity was .99 %. The identification of [ 18 F]FP-TZTP was confirmed through the co-injection with the non-radioactive analogue (Fig. 5) .
In order to decrease the purification time, it was envisaged that an analytical HPLC column could be employed instead. Once the 18 F-fluorination was complete, the reaction output from the microreactor was diluted online with water using an external syringe pump at a flow rate of 1 mL min À1 (1 : 5 dilution factor product/water) and loaded onto a Waters Oasis Ò column to preconcentrate the [ 18 F]FP-TZTP and other organic impurities (Fig. 4b) , while the aqueous stream was directed to waste. This method is efficient owing to the use of smaller HPLC columns and therefore smaller volumes of the desired product being collected. If biocompatible HPLC eluents are used (i.e. ethanol/saline), this method may negate the need for further reformulation of the final product. [24] In our hands, the HPLC preconcentration step was effective as the aqueous waste from this process was evaluated by radio-HPLC to contain .99.5 % of the [ Ò cartridge and washed, the HPLC pump and eluent were switched to the appropriate mobile phase and the contents of the Oasis Ò cartridge were injected onto an analytical monolithic HPLC column. Following collection of the desired product peak (at 3-5 min), the solution was reformulated using SPE as described above. Using this method of purification led to the production of [ (Fig. 6) . The reaction was then repeated; however, the solution was diluted online with water at 1 mL min À1 , collected, and analysed by radio-HPLC, and found to contain 25 % [ (Fig. 7) . These results indicated that the online dilution with water led to a significant decrease in the RCY of [ 
Conclusion
We have demonstrated the first method for the microfluidic radiolabelling of the muscarinic M 2 imaging agent [ 18 F]FP-TZTP. Using continuous-flow microfluidics allowed the fluorine-18 radiolabelling conditions to be rapidly optimised. Through this process, it was found that higher concentrations of the mesyl FP-TZTP precursor led to decreased 18 F-incorporation, which is in contrast to most examples of 18 F-radiotracers. Using a commercially available mesylate salt precursor obviated purity issues that had resulted in decreased RCY in the past. Therefore, the microfluidic production of [ 18 F]FP-TZTP from the mesylate salt was an improvement in terms of RCY, molar activity, amount of precursor mass used, and total synthesis time. Our results were comparable with what had been achieved previously by using a tosylate precursor, although in our case, we were also able to significantly decrease the amount of precursor required. The production of [ 18 F]FP-TZTP is susceptible to hydrolysis under aqueous conditions and therefore purification using a preconcentration step and online dilution with water was unsuitable. To further decrease purification times for [ Radiosynthesis was performed using the NanoTek Microfluidic Synthesis System with NanoTek v1.4.1 software (Advion, Ithaca, NY, USA) with in-house modifications as described previously. [15] MP-1 resins (mini-cartridge) were obtained from ORTG (Oakdale, TN, USA). (These are no longer available through ORTG; however, micro-QMA cartridges can be purchased from MedChem Imaging (Boston, MA, USA).) Sep-Pak C18 Light SPE cartridges were purchased from Waters (Sydney, NSW). Radio-HPLC was performed using a Waters 515 pump and radioactivity was measured using a Capintec R15C dose calibrator. Radio-TLC was performed using silica plates (100 % ethyl acetate) and analysed using a Cyclone Plus phosphor imager (PerkinElmer, Melbourne, Vic.). (i) The reaction mixture from the microreactor was loaded into a 500 mL HPLC loop, monitored by a radiodetector viewable in the NanoTek software. The product was purified by semipreparative HPLC using a Phenomenex Luna C18(2) 250 Â 10 mm 5-mm column with 65 % CH 3 CN/35 % H 2 O þ 5 mM Et 3 N þ 5 mM NaH 2 PO 4 at 4 mL min À1 as the eluent (t R 12-15 min); or (ii) The reaction mixture from the microreactor was diluted online with water at 1 mL min À1 and loaded onto a Waters Oasis Ò HLB 20 Â 3.9 mm 25 mm column monitored by a radiodetector viewable in the NanoTek software. The precolumn was connected to an analytical Merck Chromolith high-resolution RP-18e 50 Â 4.6 mm column for further purification using 25 % CH 3 CN/75 % 0.1 M ammonium formate at 1 mL min À1 as the eluent (t R ¼ 3-5 min).
Radiochemistry
Following HPLC purification, the product peak was collected and diluted with 15 mL of H 2 O before being loaded onto a Sep-Pak C18 Light SPE cartridge. The cartridge was washed with 2 mL of H 2 O and eluted with 1.5 mL EtOH into the vial of an additional NanoTek concentrator module, which acted as the reformulation reservoir. This vial was heated at 908C for 15 min and the dried residue was subsequently redissolved in 1 mL of 10 % ethanolic saline solution. Quality control radio-HPLC was performed by recording absorbance at l ¼ 254 nm using a Phenomenex Luna C18 150 Â 4.6 mm 5-mm column and 30 % CH 3 CN/70 % 0.1 M ammonium formate at 2 mL min À1 (t R ¼ 5-7 min). [ 18 F]FP-TZTP was obtained in 26 AE 10 % RCY (n ¼ 15) in 49 AE 2 min from the start of bolus delivery, with a molar activity of 182 AE 65 GBq mmol À1 at EOS. Radiochemical purity was .99 %. The identification of [ 18 F]FP-TZTP was confirmed through co-injection with the non-radioactive analogue.
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